An Oncolytic Virus Expressing a T-Cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells

Cancer Research - United States
doi 10.1158/0008-5472.can-18-1750
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

61PArming Oncolytic Adenovirus With FAP-targeting Bispecific T-Cell Engager to Improve Antitumor Efficacy

Annals of Oncology
MedicineOncologyHematology
2017English

Oncolytic Virus Expressing RANTES and IL-15 Enhances Function of CAR-modified T Cells in Solid Tumors

OncoImmunology
OncologyAllergyImmunology
2015English

Construction of an Oncolytic Herpes Simplex Virus That Precisely Targets Hepatocellular Carcinoma Cells

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Engager T Cells: A New Class of Antigen-Specific T Cells That Redirect Bystander T Cells

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody–Induced Tumor Cell Killing by Effector CD8+ T Cells

Journal of Immunology
AllergyImmunology
2019English

Antitumor Efficacy of 34.5ENVE: A Transcriptionally Retargeted and “Vstat120”-Expressing Oncolytic Virus

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Human Ectonucleotidase-Expressing CD25highTh17 Cells Accumulate in Breast Cancer Tumors and Exert Immunosuppressive Functions

OncoImmunology
OncologyAllergyImmunology
2015English

The Extra Domain a From Fibronectin Targets Antigens to TLR4-Expressing Cells and Induces Cytotoxic T Cell Responses in Vivo

Journal of Immunology
AllergyImmunology
2007English

Maintenance and Modification of Mesenchymal Stromal Cell Immunosuppressive Phenotype

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy